Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non‐alcoholic fatty liver disease
Open Access
- 1 June 2018
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 73 (4) , 612-621
Abstract
Aims: The composition of several important extracellular matrix components (ECM) has not yet been elucidated in human non‐alcoholic fatty liver disease (NAFLD). We aim to investigate the proportion of hepatic stellate cells (HSCs) and activity of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) in human NAFLD liver tissue with respect to severity of inflammation and fibrosis.Methods and results: Histopathological features were quantified by NAFLD activity score and grading assignment. The collagen proportionate area (CPA) was measured. Slides were stained with alpha‐smooth muscle actin (α‐SMA), as a marker of activated HSCs, and α‐SMA was quantified digitally. Zymography was performed to measure the proteolytic activity of MMP‐2 and MMP‐9. TIMP‐1 and TIMP‐2 protein concentration was measured with enzyme‐linked immunosorbent assay (ELISA). α‐SMA was higher in severe fibrosis (6.3%, interquartile range 2.9–13.1) than mild and no fibrosis (median 1.1 and 0.9%, P < 0.001) and correlated strongly with CPA (Rs = 0.870, P < 0.001). ProMMP‐2 activity in severe (4.1%, IQR 2.6–16.2) and mild fibrosis (2.7%, IQR 1.9–3.9) was higher than in no fibrosis (1.5%, (IQR 0.95–2.1); P = 0.001 and P = 0.046) and showed a moderate positive correlation with CPA (Rs = 0.495, P = 0.001). TIMP‐1 and TIMP‐2 were significantly higher in severe fibrosis than mild or no fibrosis. Both showed moderate correlation with CPA (TIMP‐1: Rs = 0.471, P = 0.002 and TIMP‐2: Rs = 0.325, P = 0.036). MMP‐9 correlated as the only ECM component to inflammation severity.Conclusions: Advanced human NAFLD‐fibrosis has a distinct ECM composition with increased HSCs and increased TIMP inhibition, but there is also ongoing remodelling activity of MMP‐2.Keywords
This publication has 34 references indexed in Scilit:
- Biospecimen Reporting for Improved Study Quality (BRISQ)Journal of Proteome Research, 2011
- Computer-assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient #Hepatology, 2009
- Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF‐β as major players and therapeutic targetsJournal of Cellular and Molecular Medicine, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteinsGut, 2004
- Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in ratsHepatology, 2004
- TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMPBiochemical Journal, 2003
- Extracellular Matrix Degradation and the Role of Hepatic Stellate CellsSeminars in Liver Disease, 2001
- Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human liversHepatology, 1997
- Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liverGastroenterology, 1996